RT Journal Article
SR Electronic
T1 Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e004233
DO 10.1136/jitc-2021-004233
VO 10
IS 3
A1 Lheureux, Stephanie
A1 Matei, Daniela E
A1 Konstantinopoulos, Panagiotis A
A1 Wang, Ben X
A1 Gadalla, Ramy
A1 Block, Matthew S
A1 Jewell, Andrea
A1 Gaillard, Stephanie L
A1 McHale, Michael
A1 McCourt, Carolyn
A1 Temkin, Sarah
A1 Girda, Eugenia
A1 Backes, Floor J
A1 Werner, Theresa L
A1 Duska, Linda
A1 Kehoe, Siobhan
A1 Colombo, Ilaria
A1 Wang, Lisa
A1 Li, Xuan
A1 Wildman, Rachel
A1 Soleimani, Shirin
A1 Lien, Scott
A1 Wright, John
A1 Pugh, Trevor
A1 Ohashi, Pamela S
A1 Brooks, David G
A1 Fleming, Gini F
YR 2022
UL http://jitc.bmj.com/content/10/3/e004233.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.